Author:
Paul Devchand,Cowan Kenneth H.
Reference315 articles.
1. Piccart, M. J., L. Biganzoli, and J. A. Roy. 1996. Adjuvant systemic therapy for breast cancer. Curr. Opin. Oncol. 8: 478–484.
2. Robert, N. J. 1997. Clinical efficacy of tamoxifen. Oncology (Huntingt). 11 (2 Suppl 1): 15–20.
3. Banerjee, D., E. Ercikan-Abali, M. Waltham, B. Schnieders, D. Hochhauser, W. W. Li, J. Fan, R. Gorlick, E. Goker, and J. R. Bertino. 1995. Molecular mechanisms of resistance to antifolates, a review. Acta Biochim. Pol. 42: 457–464.
4. Goldman, I. D., N. S. Lichtenstein, and V. T. Oliverio. 1968. Carrier-mediated transport of the folic acid analogue, methotrexate, in L1210 leukemia cells. J. Biol. Chem. 243: 5007.
5. Kessel, D., T. C. Hall, D. Roberts, et al. 1965. Uptake as a determinant of methotrexate resistance in mouse leukemias. Science 150: 752.